|
Clinical Preventive Services –
Screening - Neoplastic Diseases -
Cervical Cancer
ACPM Recommendations:
Screening for cervical cancer by
regular Pap tests should be performed in
all women who are or have been sexually
active, and should be instituted after a
woman first engages in sexual
intercourse. If the sexual history is
unknown or considered unreliable,
screening should begin at age 18. At
least two initial screening tests should
be performed one year apart. For women
who have had at least two normal annual
smears, the screening interval may then
be lengthened at the discretion of the
patient and physician after considering
the presence of risk factors, but should
not exceed three years. Screening may be
discontinued at age 65 if the following
criteria are met: the woman has been
regularly screened, has had two
satisfactory smears, and has had no
abnormal smears within the previous nine
years. For all women over age 65 who
have not been previously screened, three
normal annual smears should be
documented prior to discontinuation of
screening. Clinicians should use proper
techniques in collecting specimens,
should submit them to qualified
cytopathologic laboratories for
analysis, and should provide appropriate
follow up on test results.
- See the entire ACPM recommendation
at:
Cervical Cancer Screening.
William M. Marine, MD, FACPM and
residents at the University of Colorado
Health Service Center. Am J Prev Med.
September/October 1996.
U.S. Preventive Services Task Force
Recommendations:
Routine screening for cervical cancer
with Papanicolaou (Pap) testing is
recommended for all women who are or
have been sexually active and who have a
cervix. Pap smears should begin with the
onset of sexual activity and should be
repeated at least every 3 years (see Clinical
Intervention). There is insufficient
evidence to recommend for or against an
upper age limit for Pap testing, but
recommendations can be made on other
grounds to discontinue regular testing
after age 65 in women who have had
regular previous screenings in which the
smears have been consistently normal.
There is insufficient evidence to
recommend for or against routine
screening with cervicography or
colposcopy, or for screening for human
papilloma virus infection, although
recommendations against such screening
can be made on other grounds (see
Clinical Intervention).
|